Pediatric Piperacillin/Tazobactam 1g/0.125g Vial from Canada
Low-dose 1g piperacillin with 0.125g tazobactam vial for neonatal sepsis treatment via IV. HTS 3004.10.50.48 for this salt-containing combo in measured pediatric doses for prophylactic therapy. Dosing adjusted for weight-based administration.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Pediatric-specific stability data; smaller vial sizes reduce waste
• USP <0881> syringeability testing for neonates; amber vials for light protection
• Declare age-specific indications to support classification